Page last updated: 2024-08-17

levodopa and pergolide

levodopa has been researched along with pergolide in 147 studies

Research

Studies (147)

Timeframe	Studies, this research(%)	All Research%
pre-1990	48 (32.65)	18.7374
1990's	30 (20.41)	18.2507
2000's	57 (38.78)	29.6817
2010's	11 (7.48)	24.3611
2020's	1 (0.68)	2.80

Authors

Authors	Studies
Koller, WC	1
Clow, A; Dexter, D; Glover, V; Hussain, T; Sandler, M; Walker, M	1
Ahlskog, JE; Bailey, PA; Muenter, MD; Stevens, PM	1
Ahlskog, JE; Carmichael, SW; Kelly, PJ; Nelson, A; Okazaki, H; Richelson, E; Stoddard, SL; Tyce, GM; van Heerden, JA	1
Jacobs, MB; Varon, J	1
Davis, A; Jenner, P; Marsden, CD	1
Sage, JI; Zimmerman, T	1
Rinne, UK	2
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG	1
Jenner, P; Marsden, CD	1
Baumann, G; Chin, L; Lieberman, A	1
Boyce, S; Jenner, P; Marsden, CD	1
Goldstein, M; Leibowitz, M; Lieberman, AN	1
Ahlskog, JE; Muenter, MD	2
Delwaide, PJ; Gonce, M	1
Lieberman, AN	1
Jankovic, J; Orman, J	1
Alberts, MJ; Olanow, CW	1
Klawans, HL; Paleologos, N	1
Boyce, S; De Ceballos, ML; Jenner, P; Marsden, CD	1
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM	2
Diamond, SG; Markham, CH; Treciokas, LJ	1
Jankovic, J	3
Duvoisin, RC; Sage, JI	1
Goldstein, M; Lieberman, AN	1
Gopinathan, G; Lieberman, AN; Neophytides, A	1
Agid, Y; Dubois, B	1
Askenasy, JJ; Yahr, MD	1
Burton, K; Calne, DB	1
Beckman, J; Burton, K; Calne, DB; Martin, WR	1
Glatt, S; Goetz, CG; Klawans, HL; Tanner, CM	1
Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD	1
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L	1
De Bruyne, H; Jeanty, P; Lowenthal, A; Van den Kerchove, M	1
Goldstein, M; Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Nelson, J; Neophytides, A; Walker, R	2
Agid, Y; Barroche, G; de Smet, Y; Lhermitte, F; Mear, JY; Weber, M	1
Fahn, S; Jackson-Lewis, V; Reches, A; Wagner, HR; Yablonskaya-Alter, E	1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, NP; Thompson, C	1
Diamond, SG; Markham, CH	1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N	1
Cote, LJ; Fahn, S; Ilson, J; Mayeux, R; Snider, SR	1
Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R	1
Glantz, RH; Glatt, SL; Goetz, CG; Klawans, HL; Tanner, CM	1
Klawans, HL; Tanner, CM	1
Goldstein, M; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R	1
Goldstein, M; Kleinberg, D; Kupersmith, M; Leibowitz, M; Lieberman, A; Neophytides, A; Pact, V	1
Goldstein, M; Gopinathan, G; Kupersmith, M; Leibowitz, M; Lieberman, A; Mehl, S; Neophytides, A	1
Eadie, MJ	1
Angeleri, V; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G	1
Mark, MH; Sage, JI	1
Angeleri, VA; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G	1
Fahn, S; Grimes, JD; Hurtig, H; Jankovic, J; Klawans, H; Kurlan, R; Muenter, M; Olanow, CW; Shoulson, I; Stern, M	1
Comella, CL; Ristanovic, RK; Tanner, CM	1
Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I	1
Ahlskog, JE	1
Dethy, S; Goldman, S; Hildebrand, J; Laute, MA; Luxen, A	1
Facca, A; Sanchez-Ramos, J	1
Kuno, S	1
Allen, RP; Earley, CJ	1
Scheidtmann, K; Schwarz, J; Trenkwalder, C	1
Cabrera-Valdivia, F; Fernández-Lliria, A; Gasalla, T; Jiménez-Jiménez, FJ; Ortí-Pareja, M; Tallón-Barranco, A	1
Hajak, G; Rüther, E; Staedt, J; Stoppe, G; Wassmuth, F; Ziemann, U	1
de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R	1
Oertel, WH; Stiasny, K; Trenkwalder, C; Wetter, TC; Winkelmann, J	1
Amano, K; Takakura, K	1
Damhaut, P; Dethy, S; Goldman, S; Laute, MA	1
Weiner, WJ	1
Montastruc, JL; Rascol, O; Senard, JM	1
Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S	1
Ahlskog, JE; Burnett, OL; Maraganore, DM; Matsumoto, JY; O'Connor, MK; Stark, KF; Turk, MF; Uitti, RJ	1
Clarke C, E; Speller J, M	2
Bisulli, A; Nassetti, SA; Santangelo, M; Strafella, AP; Tassinari, CA; Tropeani, A; Valzania, F	1
Barbanoj, M; Berthier, ML; Estévez-González, A; García-Sánchez, C; Gironell, A; Kulisevsky, J; Pascual-Sedano, B	1
Kesler, S; Niehaus, DJ; Seedat, S; Stein, DJ	1
Hickey, J	1
Crevits, L; De Ridder, K; Hanse, M; Versijpt, J	1
Sternon, J; Supiot, F; Zegers de Beyl, D	1
Masson, C	1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A	1
Doder, M; Hely, M; Koller, W; Lees, A	1
Hillman, R; Parvez, F; Pendleton, RG; Sayed, M	1
Alexander, MP	1
Bartalini, S; Battistini, N; Giannini, F; Lombardi, C; Lugaresi, E; Passero, S; Rocchi, R; Rossi, S; Ulivelli, M	1
De Mari, M; Lamberti, P; Zenzola, A	1
Yokochi, F	1
Gille, G; Hundemer, HP; Hung, ST; Janetzky, B; Kolter, T; Moldzio, R; Rausch, WD; Reichmann, H	1
Clarke, CE; Guttman, M	1
Bonnet, AM; Houeto, JL	1
Cannizzaro, C; Jackson, MJ; Jenner, P; Maratos, EC; Pearce, RK	1
MacMahon, DG	1
Diemont, WL; van Puijenbroek, EP	1
Bares, M; Dostál, V; Ehler, E; Fanfrdlová, Z; Fiedler, J; Klajblová, H; Kulist'ák, P; Rektor, I; Rektorová, I; Ressner, P; Svátová, J; Urbánek, K; Velísková, J	1
de la Llave, Y; Garcia de Yébenes, J; Garcia-Borreguero, D; Larrosa, O; Schwarz, C	1
Iranzo, A; Santamaria, J; Tolosa, E	1
Burkhard, PR; Flachsbart, KD; Fross, RD; Horvath, J; Kleiner-Fisman, G; Lang, AE; Lerch, R; Liaudat, S; Pache, JC; Rakowski, H; Raskoff, WJ; Stalder, H	1
Grosset, D; Grosset, K; Macphee, G; Needleman, F	1
Clarke, CE; Deane, KH; Spieker, S	1
Ludin, HP	1
Chen, SD; Chen, Y; Li, B; Liu, WG; Lu, GQ	1
Gerlach, M; Reichmann, H; Riederer, P	1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C	1
Comella, CL; Janko, K; Morrissey, M	1
Kishore, A; Lang, AE	1
Bares, M; Kanovský, P; Pohanka, M; Pulkrábek, J; Rektor, I	1
Arnold, G; Bergamasco, B; Dujardin, M; Frewer, P; Gimenez-Roldan, S; Grosset, DG; Hundemer, HP; Leenders, KL; Lledó, A; Oertel, WH; Sampaio, C; Schwarz, J; Wolters, E; Wood, A	1
Cannas, A; Floris, G; Solla, P; Tacconi, P	1
Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G	1
Antal, A; Lampe, C; Lang, N; Liebetanz, D; Nitsche, MA; Paulus, W; Tergau, F	1
Chan, PL; Holford, NH; Kieburtz, K; Nutt, JG; Shoulson, I	1
Bernardi, S; Meco, G	1
Larner, AJ	1
de Freitas, GR; Fontenelle, LF; Garcia, RF; Mendlowicz, MV; Nazar, BP; Ordacgi, L; Rosso, AL	1
Barget, M; Debilly, B; Derost, PP; Durif, F; Lemaire, JJ; Llorca, PM; Morand, D; Ouchchane, L; Ulla, M	1
Ahmed, MR; Bychkov, E; Dalby, KN; Gurevich, EV	1
Boon, P; De Bodt, M; De Letter, M; Estercam, I; Santens, P; Van Borsel, J; Van Maele, G	1
Funakoshi, T; Iwata, S; Wakamatsu, M; Yoshimoto, M	1
Ahmed, MR; Benovic, JL; Bychkov, E; Gurevich, EV; Gurevich, VV	1
Bejjani, BP; Jabre, MG	1
Bordet, R; Derambure, P; Destée, A; Houdayer, E; Jacquesson, JM; Laloux, C; Monaca, C	1
Dupuis, M; Evrard, F; Jacquerye, P; Muller, T	1
Duong-Hua, M; Lang, A; Marras, C; Rochon, P; Sykora, K; Zadikoff, C	1
Bares, M; Krajcovicová, L; Rektor, I; Rektorová, I	1
Aydemir, T; Bader, H; Cetin, S; Kizkin, S; Meral, H; Ozben, B; Ozben, S; Ozer, F; Ozturk, O; Tiras, R	1
Cannas, A; Floris, G; Marrosu, F; Marrosu, MG; Piga, M; Serra, A; Solla, P; Tacconi, P	1
Arai, M	1
Hornyak, M; Kohnen, R; Kriston, L; Riemann, D; Scholz, H; Trenkwalder, C	1
Allen, RP; Ball, E; Calloway, MO; Higbie, RL; Lee, MR; Manjunath, R; Nisbet, PA; Ondo, WG	1
Adam, JJ; Duits, A; Scholtissen, B; van Houdt, H; Visser-Vandewalle, V; Winogrodzka, A	1
Aurora, RN; Bista, SR; Casey, KR; Kristo, DA; Lamm, CI; Rosenberg, RS; Rowley, JA; Tracy, SL; Zak, RS	1
Damier, P; Derkinderen, P; Giumelli, B; Meyniel, C	1
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H	1
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ	1
Ikeda, S; Ishizaki, T; Nakaoka, S; Nakayama, T; Satoh, T; Urushihara, H; Yamamoto, M	1
Jenner, P; Kanda, T; Kawai-Uchida, M; Mori, A; Okita, E; Soshiroda, K; Uchida, S	2
Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C	1

Reviews

23 review(s) available for levodopa and pergolide

Article	Year
Initiating treatment of Parkinson's disease. Neurology, 1992, Volume: 42, Issue:1 Suppl 1 Topics: Amantadine; Antioxidants; Dopamine Agents; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide	1992
Medical treatment of pituitary adenomas: effects on tumor growth. Journal of endocrinological investigation, 1985, Volume: 8, Issue:3 Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed	1985
Chronic pharmacological manipulation of dopamine receptors in brain. Neuropharmacology, 1987, Volume: 26, Issue:7B Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain; Bromocriptine; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Pergolide; Receptors, Dopamine; Trifluoperazine	1987
Receptor changes during chronic dopaminergic stimulation. Journal of neural transmission. Supplementum, 1988, Volume: 27 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome	1988
Long-term use of dopamine agonists in Parkinson's disease. Clinical neuropharmacology, 1985, Volume: 8, Issue:2 Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors	1985
Bromocriptine in Parkinson disease. Pharmacological reviews, 1985, Volume: 37, Issue:2 Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1985
The pharmacology of Parkinson's disease: basic aspects and recent advances. Experientia, 1984, Nov-15, Volume: 40, Issue:11 Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine	1984
Treatment of early Parkinson's disease: are complicated strategies justified? Mayo Clinic proceedings, 1996, Volume: 71, Issue:7 Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Selegiline	1996
[Treatment of Parkinson's disease with multiple drugs]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1 Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide	1997
The initial treatment of Parkinson's disease should begin with levodopa. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors	1999
Treatment of Parkinson's disease should begin with a dopamine agonist. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5 Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles	1999
Pergolide for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide	2000
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease. The Cochrane database of systematic reviews, 2000, Issue:2 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide	2000
Restless legs syndrome. Canadian family physician Medecin de famille canadien, 2000, Volume: 46 Topics: Diagnosis, Differential; Dopamine Agents; Evidence-Based Medicine; Humans; Levodopa; Nocturnal Myoclonus Syndrome; Pergolide; Practice Guidelines as Topic; Restless Legs Syndrome	2000
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4 Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone	2002
Dopamine agonist monotherapy in Parkinson's disease. Lancet (London, England), 2002, Nov-30, Volume: 360, Issue:9347 Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon	2002
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease. The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4 Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone	2004
[Are there innovations in the treatment of Parkinson's disease?]. Praxis, 2004, Nov-03, Volume: 93, Issue:45 Topics: Antiparkinson Agents; Cannabis; Cholinesterase Inhibitors; Controlled Clinical Trials as Topic; Dopamine Agonists; Heart Valve Diseases; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Pergolide; Phenylcarbamates; Placebos; Rivastigmine; Time Factors	2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone	2005
Dopamine agonists for restless legs syndrome. The Cochrane database of systematic reviews, 2011, Mar-16, Issue:3 Topics: Benzothiazoles; Cabergoline; Dopamine Agonists; Ergolines; Humans; Levodopa; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Restless Legs Syndrome; Severity of Illness Index	2011
The treatment of restless legs syndrome and periodic limb movement disorder in adults--an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep, 2012, Aug-01, Volume: 35, Issue:8 Topics: Academies and Institutes; Benzothiazoles; Cabergoline; Carbamates; Dopamine Agents; Ergolines; Evidence-Based Medicine; gamma-Aminobutyric Acid; Humans; Indoles; Levodopa; Nocturnal Myoclonus Syndrome; Pergolide; Peripheral Nervous System Diseases; Pramipexole; Restless Legs Syndrome; Sleep Medicine Specialty; United States; Venous Insufficiency	2012
Anti-Parkinson's disease drugs and pharmacogenetic considerations. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7 Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline	2013
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis. European journal of pharmacology, 2023, Sep-05, Volume: 954 Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole	2023

Trials

32 trial(s) available for levodopa and pergolide

Article	Year
Pergolide and selegiline for Parkinson's disease. The Medical letter on drugs and therapeutics, 1989, Sep-08, Volume: 31, Issue:800 Topics: Animals; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Nerve Degeneration; Parkinson Disease; Pergolide; Phenethylamines; Selegiline	1989
Treatment of Parkinson's disease with pergolide: a double-blind study. Mayo Clinic proceedings, 1988, Volume: 63, Issue:10 Topics: Activities of Daily Living; Adult; Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Random Allocation	1988
Pergolide: long-term use in Parkinson's disease. Mayo Clinic proceedings, 1988, Volume: 63, Issue:10 Topics: Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Placebos; Retrospective Studies	1988
Parallel double-blind study of pergolide in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Parkinson Disease; Pergolide; Random Allocation	1987
Double-blind controlled study of pergolide mesylate as an adjunct to Sinemet in the treatment of Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Random Allocation	1987
Double-blind trial of pergolide for Parkinson's disease. Neurology, 1985, Volume: 35, Issue:3 Topics: Aged; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Ergolines; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1985
Pergolide therapy in Parkinson's disease: a double-blind, placebo-controlled study. Clinical neuropharmacology, 1985, Volume: 8, Issue:3 Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Ergolines; Gait; Humans; Levodopa; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Pergolide; Random Allocation	1985
Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy. Neurology, 1983, Volume: 33, Issue:4 Topics: Adult; Aged; Antiparkinson Agents; Bulbar Palsy, Progressive; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Placebos	1983
A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's disease. Advances in neurology, 1983, Volume: 37 Topics: Clinical Trials as Topic; Disability Evaluation; Ergolines; Female; Humans; Levodopa; Male; Parkinson Disease; Pergolide; Sleep; Time Factors	1983
Comparison of pergolide and bromocriptine therapy in parkinsonism. Neurology, 1983, Volume: 33, Issue:8 Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1983
Pergolide in late-stage Parkinson disease. Annals of neurology, 1982, Volume: 12, Issue:3 Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders	1982
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease. Neurology, 1995, Volume: 45, Issue:3 Suppl 3 Topics: Aged; Bromocriptine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1995
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4 Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide; Single-Blind Method; Treatment Outcome	1994
A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:1 Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Electrocardiography; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Pergolide	1994
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1995
Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:4-5 Topics: Aged; Carbidopa; Circadian Rhythm; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Myoclonus; Pergolide; Restless Legs Syndrome; Sleep; Syndrome; Treatment Outcome	1997
Treatment of restless leg syndrome with pergolide--an open clinical trial. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:3 Topics: Aged; Antiparkinson Agents; Domperidone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Pergolide; Restless Legs Syndrome; Treatment Outcome	1998
Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist? Stereotactic and functional neurosurgery, 1997, Volume: 69, Issue:1-4 Pt 2 Topics: Aged; Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Stereotaxic Techniques; Treatment Outcome	1997
The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6 Topics: Aged; Brain; Brain Mapping; Carbidopa; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Motor Skills; Nerve Tissue Proteins; Parkinson Disease; Pergolide; Putamen; Tomography, Emission-Computed, Single-Photon	1999
Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2000, Volume: 111, Issue:7 Topics: Aged; Analysis of Variance; Drug Administration Schedule; Drug Therapy, Combination; Electric Stimulation; Humans; Levodopa; Middle Aged; Motor Cortex; Neural Inhibition; Parkinson Disease; Pergolide; Reaction Time; Sensory Thresholds; Severity of Illness Index; Transcranial Magnetic Stimulation	2000
Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients. Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:4 Topics: Aged; Antiparkinson Agents; Cognition Disorders; Dopamine Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neuropsychological Tests; Parkinson Disease; Pergolide	2000
Antisaccadic effects of a dopamine agonist as add-on therapy in advanced Parkinson's patients. Neuropsychobiology, 2000, Volume: 42, Issue:4 Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Female; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Saccades	2000
Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations. Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:5 Topics: Antiparkinson Agents; Benzophenones; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nitrophenols; Parkinson Disease; Pergolide; Quality of Life; Tolcapone; Treatment Outcome	2001
[Pergolide: a useful agonist for the treatment of Parkinson disease]. Revue neurologique, 2002, Volume: 158, Issue:6-7 Topics: Antiparkinson Agents; Disease Progression; Dopamine Agonists; Dyskinesia, Drug-Induced; Electric Stimulation Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	2002
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. European journal of neurology, 2003, Volume: 10, Issue:4 Topics: Activities of Daily Living; Aged; Analysis of Variance; Antiparkinson Agents; Benzothiazoles; Cross-Over Studies; Depression; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Pergolide; Placebos; Pramipexole; Prospective Studies; Psychiatric Status Rating Scales; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome	2003
L-DOPA-induced excessive daytime sleepiness in PD: a placebo-controlled case with MSLT assessment. Neurology, 2003, Oct-14, Volume: 61, Issue:7 Topics: Aged; Antiparkinson Agents; Disorders of Excessive Somnolence; Double-Blind Method; Female; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Reaction Time; Selegiline	2003
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology, 2005, Apr-26, Volume: 64, Issue:8 Topics: Age Factors; Aged; Antiparkinson Agents; Brain; Circadian Rhythm; Constipation; Dizziness; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Pergolide; Placebos; Sex Factors; Sleep; Sleep Wake Disorders; Treatment Outcome	2005
The long-lasting improvement of sexual dysfunction in patients with advanced, fluctuating Parkinson's disease induced by pergolide: evidence from the results of an open, prospective, one-year trial. Parkinsonism & related disorders, 2005, Volume: 11, Issue:8 Topics: Aged; Antiparkinson Agents; Erectile Dysfunction; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Prolactin; Prospective Studies; Sexual Dysfunction, Physiological	2005
Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:3 Topics: Adult; Age of Onset; Aged; Brain; Dopamine Agonists; Double-Blind Method; Dyskinesias; Early Diagnosis; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Prospective Studies; Radionuclide Imaging; Surveys and Questionnaires	2006
Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex. The European journal of neuroscience, 2006, Volume: 23, Issue:6 Topics: Adult; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Electrophysiology; Female; Humans; Levodopa; Magnetoencephalography; Male; Motor Cortex; Neuronal Plasticity; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Transcranial Magnetic Stimulation	2006
Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:1 Topics: Adult; Aged; Analysis of Variance; Case-Control Studies; Dopamine Agonists; Drug Therapy, Combination; Echocardiography; Female; Heart Valve Diseases; Humans; Levodopa; Logistic Models; Male; Middle Aged; Parkinson Disease; Pergolide; Single-Blind Method; Young Adult	2009
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:3 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3	2013

Other Studies

92 other study(ies) available for levodopa and pergolide

Article	Year
Pergolide can induce soluble superoxide dismutase in rat striata. Journal of neural transmission. General section, 1992, Volume: 90, Issue:1 Topics: Animals; Brain Chemistry; Corpus Striatum; Cytosol; Dopamine; Enzyme Induction; Isatin; Levodopa; Male; Mitochondria; Pergolide; Rats; Rats, Wistar; Selegiline; Subcellular Fractions; Superoxide Dismutase	1992
Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide) Archives of neurology, 1992, Volume: 49, Issue:5 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Lactose; Levodopa; Male; Methylcellulose; Middle Aged; Oxazines; Parkinson Disease; Pergolide	1992
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients. Annals of neurology, 1991, Volume: 30, Issue:2 Topics: Adult; Brain Tissue Transplantation; Bromocriptine; Caudate Nucleus; Down-Regulation; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Neurotransmitter; Spiperone	1991
Treating the progressive stages of Parkinson's disease. Postgraduate medicine, 1991, Volume: 90, Issue:1 Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline	1991
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour. Psychopharmacology, 1990, Volume: 100, Issue:1 Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride	1990
Comparison of combination pergolide and levodopa to levodopa alone after 63 months of treatment. Clinical neuropharmacology, 1991, Volume: 14, Issue:2 Topics: Aged; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Statistics as Topic	1991
Early dopamine agonist therapy in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4 Suppl 1 Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine	1989
MK 458, a selective and potent D2 receptor agonist in advanced Parkinson's disease. Clinical neuropharmacology, 1988, Volume: 11, Issue:3 Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Dopamine Agents; Female; Humans; Hypromellose Derivatives; Lactose; Levodopa; Lisuride; Methylcellulose; Middle Aged; Nausea; Oxazines; Parkinson Disease; Pergolide; Psychomotor Performance; Receptors, Dopamine	1988
Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease. New York state journal of medicine, 1988, Volume: 88, Issue:8 Topics: Adult; Aged; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies	1988
Dopamine agonists as primary treatment in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine	1987
[Clinical study of pergolide in Parkinson's disease]. Presse medicale (Paris, France : 1983), 1985, Jun-29, Volume: 14, Issue:26 Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Pergolide	1985
Treatment of Parkinson's disease. Mayo Clinic proceedings, 1988, Volume: 63, Issue:10 Topics: Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide	1988
International symposium on early dopamine agonist therapy of Parkinson's disease. Archives of neurology, 1988, Volume: 45, Issue:2 Topics: Animals; Bromocriptine; Carbidopa; Dopamine; Humans; Levodopa; Parkinson Disease; Pergolide; Time Factors	1988
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists. Clinical neuropharmacology, 1986, Volume: 9, Issue:3 Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis	1986
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats. European journal of pharmacology, 1986, Nov-04, Volume: 130, Issue:3 Topics: Animals; Basal Ganglia; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neurotensin; Pergolide; Rats; Rats, Inbred Strains; Trifluoperazine	1986
Pergolide mesylate: four years experience in Parkinson's disease. Advances in neurology, 1987, Volume: 45 Topics: Adult; Aged; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1987
Efficacy of pergolide and mesulergine. European neurology, 1986, Volume: 25, Issue:2 Topics: Aged; Antiparkinson Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide	1986
[Dopaminergic agonists in Parkinson disease]. La Revue du praticien, 1986, Jan-21, Volume: 36, Issue:5 Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil	1986
Long-term study of pergolide in Parkinson's disease. Neurology, 1985, Volume: 35, Issue:3 Topics: Adult; Aged; Disability Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1985
Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology, 1985, Volume: 35, Issue:4 Topics: Aged; Carbidopa; Drug Combinations; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Receptors, Dopamine; Sleep Wake Disorders; Sleep, REM	1985
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Neurology, 1985, Volume: 35, Issue:5 Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors	1985
Dopamine agonists and Parkinson's disease. Clinical neurology and neurosurgery, 1984, Volume: 86, Issue:3 Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine	1984
Dopamine agonists in Parkinson's disease. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2	1984
Pergolide therapy in Parkinson's disease. Journal of neurology, 1984, Volume: 231, Issue:3 Topics: Aged; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1984
Long-term treatment with pergolide: decreased efficacy with time. Neurology, 1984, Volume: 34, Issue:2 Topics: Aged; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1984
Pergolide in the treatment of Parkinson's disease. Neurology, 1984, Volume: 34, Issue:7 Topics: Adult; Aged; Carbidopa; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1984
Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum. Neurology, 1984, Volume: 34, Issue:9 Topics: Animals; Corpus Striatum; Denervation; Ergolines; Levodopa; Male; Parkinson Disease; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine	1984
Pergolide in the treatment of Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Antiparkinson Agents; Domperidone; Ergolines; Humans; Levodopa; Mental Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Pergolide	1984
One-year trial of pergolide as an adjunct to Sinemet in treatment of Parkinson's disease. Advances in neurology, 1984, Volume: 40 Topics: Athetosis; Carbidopa; Chorea; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Hypotension; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1984
Pergolide treatment in parkinsonism. Advances in neurology, 1983, Volume: 37 Topics: Adult; Aged; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Respiration Disorders	1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease. Advances in neurology, 1983, Volume: 37 Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors	1983
Pergolide mesylate and idiopathic Parkinson disease. Neurology, 1982, Volume: 32, Issue:10 Topics: Adolescent; Adult; Carbidopa; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Parkinson Disease; Pergolide	1982
Further studies with pergolide in Parkinson disease. Neurology, 1982, Volume: 32, Issue:10 Topics: Adult; Aged; Carbidopa; Confusion; Drug Combinations; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	1982
Pergolide mesylate: new therapy for Parkinson disease. Annals of internal medicine, 1982, Volume: 96, Issue:4 Topics: Antiparkinson Agents; Arrhythmias, Cardiac; Ergolines; Humans; Levodopa; Parkinson Disease; Pergolide	1982
The use of pergolide, a potent dopamine agonist, in Parkinson's disease. Clinical pharmacology and therapeutics, 1982, Volume: 32, Issue:1 Topics: Adult; Aged; Antiparkinson Agents; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Random Allocation; Time Factors	1982
Treatment of advanced Parkinson disease with pergolide. Neurology, 1981, Volume: 31, Issue:6 Topics: Aged; Arrhythmias, Cardiac; Brain; Dopamine; Double-Blind Method; Ergolines; Humans; Levodopa; Middle Aged; Neurons; Parkinson Disease; Pergolide; Random Allocation	1981
Cardiac effects of pergolide. Clinical pharmacology and therapeutics, 1981, Volume: 30, Issue:6 Topics: Aged; Antiparkinson Agents; Arrhythmias, Cardiac; Carbidopa; Drug Therapy, Combination; Ergolines; Heart; Heart Rate; Humans; Levodopa; Middle Aged; Pergolide	1981
Treatment of Parkinson's disease. Australian family physician, 1995, Volume: 24, Issue:9 Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Pergolide; Prognosis; Selegiline	1995
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile. Annals of neurology, 1995, Volume: 37, Issue:1 Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating	1995
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Annals of neurology, 1993, Volume: 34, Issue:5 Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM	1993
Effect of pergolide on endogenous and exogenous L-DOPA metabolism in the rat striatum: a microdialysis study. Journal of neural transmission. General section, 1995, Volume: 101, Issue:1-3 Topics: Animals; Biotransformation; Chromatography, High Pressure Liquid; Dopamine Agonists; Injections, Intraventricular; Levodopa; Male; Microdialysis; Neostriatum; Pergolide; Rats; Rats, Wistar	1995
High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias. Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3 Topics: Aged; Antiparkinson Agents; Carbidopa; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide	1996
Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep, 1996, Volume: 19, Issue:10 Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Pergolide; Restless Legs Syndrome; Severity of Illness Index; Treatment Outcome	1996
Improvement of motor fluctuations in patients with Parkinson's disease following treatment with high doses of pergolide and cessation of levodopa. European neurology, 1997, Volume: 37, Issue:4 Topics: Aged; Amantadine; Antiparkinson Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Pergolide	1997
Cenesthetic hallucinations in a patient with Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:1 Topics: Aged; Clozapine; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide	1997
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease]. Revista de neurologia, 1997, Volume: 25, Issue:145 Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor	1997
Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine. Journal of neural transmission (Vienna, Austria : 1996), 1999, Volume: 106, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Synergism; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Microdialysis; Motor Activity; Neostriatum; Neurons; Oxidopamine; Parkinson Disease, Secondary; Pergolide; Rats; Rats, Wistar	1999
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data. Journal of the neurological sciences, 1999, Nov-30, Volume: 170, Issue:2 Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors	1999
Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depression and anxiety, 2000, Volume: 11, Issue:4 Topics: Antipsychotic Agents; Carbidopa; Dopamine Agonists; Drug Therapy, Combination; Female; Gambling; Humans; Impulsive Behavior; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Risperidone; Treatment Outcome	2000
[Dopaminergic agonists in the treatment of Parkinson's disease]. Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6 Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles	2000
[Parkinson's disease]. Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8 Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors	2001
Pergolide and Parkinson's disease: new preparation. No clear benefit. Prescrire international, 2000, Volume: 9, Issue:50 Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome	2000
Efficacy and tolerability of dopamine agonists in a parkinsonian population. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome	2001
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:1 Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins	2002
Chronic akinetic mutism after mesencephalic-diencephalic infarction: remediated with dopaminergic medications. Neurorehabilitation and neural repair, 2001, Volume: 15, Issue:2 Topics: Adult; Akinetic Mutism; Carbidopa; Cerebral Infarction; Chronic Disease; Diencephalon; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Magnetic Resonance Imaging; Mesencephalon; Neuropsychological Tests; Pergolide	2001
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology, 2002, Feb-12, Volume: 58, Issue:3 Topics: Adult; Disorders of Excessive Somnolence; Dopamine Agents; Dopamine Agonists; Drug Therapy, Combination; Electroencephalography; Female; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep, REM; Wakefulness	2002
Antiparkinsonian treatment in pregnancy. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:2 Topics: Adult; Antiparkinson Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Levodopa; Neurologic Examination; Parkinson Disease; Pergolide; Pregnancy; Pregnancy Complications	2002
[Multiple system atrophy which had been treated as juvenile Parkinson's disease]. No to shinkei = Brain and nerve, 2002, Volume: 54, Issue:3 Topics: Adult; Antiparkinson Agents; Humans; Levodopa; Male; Multiple System Atrophy; Parkinson Disease; Pergolide	2002
Pergolide protects dopaminergic neurons in primary culture under stress conditions. Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:5-6 Topics: 1-Methyl-4-phenylpyridinium; Animals; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Agonists; Levodopa; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Pergolide; Stress, Physiological; Tyrosine 3-Monooxygenase	2002
Both short- and long-acting D-1/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus). Experimental neurology, 2003, Volume: 179, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Levodopa; Motor Activity; Parkinsonian Disorders; Pergolide; Receptors, Dopamine D1; Receptors, Dopamine D2; Severity of Illness Index	2003
The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa. Age and ageing, 2003, Volume: 32, Issue:3 Topics: Antiparkinson Agents; Benzothiazoles; Catechol O-Methyltransferase; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Thiazoles	2003
[Hypersexuality during use of levodopa]. Nederlands tijdschrift voor geneeskunde, 2003, May-17, Volume: 147, Issue:20 Topics: Aged; Antiparkinson Agents; Drug Combinations; Humans; Levodopa; Male; Middle Aged; Pergolide; Sexual Dysfunction, Physiological	2003
Development of restless legs syndrome after dopaminergic treatment in a patient with periodic leg movements in sleep. Sleep medicine, 2003, Volume: 4, Issue:2 Topics: Dopamine Agents; Humans; Levodopa; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Pergolide; Polysomnography; Restless Legs Syndrome; Treatment Outcome	2003
Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:6 Topics: Adult; Aged; Cabergoline; Carbidopa; Dopamine Agonists; Drug Combinations; Echocardiography, Transesophageal; Ergolines; Ergot Alkaloids; Female; Heart Valve Diseases; Humans; Levodopa; Male; Parkinson Disease; Pergolide	2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11 Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles	2004
Neuroprotection by pergolide against levodopa-induced cytotoxicity of neural stem cells. Neurochemical research, 2004, Volume: 29, Issue:12 Topics: Animals; Annexin A5; Antimetabolites; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Cells, Cultured; Dopamine Agents; Flow Cytometry; Fluorescein-5-isothiocyanate; Levodopa; Mice; Neurons; Neuroprotective Agents; Pergolide; Stem Cells; Tetrazolium Salts; Thiazoles	2004
Levodopa in the treatment of Parkinson's disease: current controversies. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5 Topics: Animals; Antiparkinson Agents; Apomorphine; Disease Models, Animal; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Lisuride; Parkinson Disease; Pergolide	2005
Normalization of voice in spasmodic dysphonia during transient global amnesia. Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:9 Topics: Aged; Amnesia, Transient Global; Antiparkinson Agents; Female; Humans; Levodopa; Parkinson Disease; Pergolide; Speech Therapy; Voice Disorders; Voice Training	2005
Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation. The international journal of neuropsychopharmacology, 2006, Volume: 9, Issue:6 Topics: Antiparkinson Agents; Benserazide; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Homeostasis; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Paraphilic Disorders; Parkinson Disease; Pedophilia; Pergolide	2006
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement. Parkinsonism & related disorders, 2006, Volume: 12, Issue:5 Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Bromocriptine; Disability Evaluation; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pergolide; Prognosis; Survival Analysis	2006
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments. Journal of pharmacokinetics and pharmacodynamics, 2006, Volume: 33, Issue:3 Topics: Algorithms; Antiparkinson Agents; Bayes Theorem; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Models, Biological; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Selegiline; Treatment Outcome	2006
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease. Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jan-30, Volume: 31, Issue:1 Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Clomipramine; Clozapine; Delusions; Depressive Disorder; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders	2007
Medical hazards of the internet: gambling in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10 Topics: Adult; Antiparkinson Agents; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Gambling; Humans; Internet; Levodopa; Male; Parkinson Disease; Pergolide	2006
Treatment of juvenile Parkinson disease and the recurrent emergence of pathologic gambling. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, 2007, Volume: 20, Issue:1 Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Gambling; Humans; Levodopa; Parkinsonian Disorders; Pergolide; Pramipexole; Recurrence	2007
Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology, 2007, Apr-24, Volume: 68, Issue:17 Topics: Activities of Daily Living; Age Factors; Aged; Antiparkinson Agents; Bipolar Disorder; Catechols; Cognition; Combined Modality Therapy; Communication; Deep Brain Stimulation; Dysarthria; Electrodes, Implanted; Emotions; Female; Humans; Levodopa; Male; Middle Aged; Movement; Neuropsychological Tests; Nitriles; Parkinson Disease; Pergolide; Prejudice; Quality of Life; Severity of Illness Index; Subthalamic Nucleus; Treatment Outcome; Weight Gain	2007
Dopamine depletion and subsequent treatment with L-DOPA, but not the long-lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatum. Journal of neurochemistry, 2007, Volume: 102, Issue:3 Topics: Animals; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Levodopa; Mitogen-Activated Protein Kinase 1; Opioid Peptides; Oxidopamine; Parkinson Disease; Pergolide; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Signal Transduction; Up-Regulation	2007
Levodopa-induced modifications of prosody and comprehensibility in advanced Parkinson's disease as perceived by professional listeners. Clinical linguistics & phonetics, 2007, Volume: 21, Issue:10 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Drug Therapy, Combination; Dysarthria; Female; Humans; Levodopa; Linguistics; Male; Middle Aged; Parkinson Disease; Pergolide; Sound Spectrography; Speech Acoustics; Speech Intelligibility; Speech Production Measurement; Verbal Behavior	2007
Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease. Journal of neuroscience research, 2008, Feb-15, Volume: 86, Issue:3 Topics: alpha-Synuclein; Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Exploratory Behavior; Humans; Levodopa; Male; Mice; Mice, Transgenic; Motor Activity; Parkinson Disease; Peptide Fragments; Pergolide; Receptors, Dopamine D2	2008
Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment. Journal of neurochemistry, 2008, Volume: 104, Issue:6 Topics: Animals; Arrestins; Basal Ganglia; Dopamine; Dopamine Agents; Dopamine Agonists; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 3; G-Protein-Coupled Receptor Kinase 5; G-Protein-Coupled Receptor Kinases; Gene Expression; Levodopa; Medial Forebrain Bundle; Pergolide; Rats; Rats, Sprague-Dawley; Substantia Nigra	2008
The variability of levodopa response in Parkinson's disease: is sensitization reversible? Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-30, Volume: 23, Issue:6 Topics: Antiparkinson Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome	2008
Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice. Journal of sleep research, 2008, Volume: 17, Issue:1 Topics: Animals; Dopamine Agonists; Electroencephalography; Levodopa; Lisuride; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders; Pergolide; Polysomnography; Sleep; Wakefulness	2008
[Isolated pulmonary hypertension and pergolide]. Revue neurologique, 2008, Volume: 164, Issue:3 Topics: Antiparkinson Agents; Benserazide; Benzothiazoles; Blood Pressure; Catechols; Dyspnea; Echocardiography; Humans; Hypertension, Pulmonary; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease, Postencephalitic; Pergolide; Pramipexole	2008
Pergolide associated cardiac valvulopathy based on Ontario administrative data. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2008, Volume: 35, Issue:2 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Databases, Factual; Dopamine Agonists; Female; Health Services Administration; Heart Failure; Heart Valve Diseases; Humans; Levodopa; Male; Ontario; Parkinson Disease; Pergolide	2008
Heart valve abnormalities in Parkinson's disease treated with dopamine agonists. Journal of neurology, 2008, Volume: 255, Issue:10 Topics: Antiparkinson Agents; Benzothiazoles; Dopamine Agonists; Echocardiography; Female; Heart Valve Diseases; Heart Valves; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole	2008
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy. Journal of neurology, 2009, Volume: 256, Issue:3 Topics: Aged; Aged, 80 and over; Benserazide; Benzothiazoles; Brain; Carbidopa; Dopamine Agents; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Tomography, Emission-Computed, Single-Photon; Tropanes	2009
Increased plasma arginine vasopressin levels in dopamine agonist-treated Parkinson's disease patients. Neuro endocrinology letters, 2011, Volume: 32, Issue:1 Topics: Aged; Arginine Vasopressin; Benzothiazoles; Carbidopa; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole	2011
Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep medicine, 2011, Volume: 12, Issue:5 Topics: Adult; Aged; Benzothiazoles; Cross-Sectional Studies; Dopamine Agonists; Female; Health Surveys; Humans; Indoles; Levodopa; Male; Middle Aged; Outpatients; Patient Satisfaction; Pergolide; Pramipexole; Restless Legs Syndrome; Risk Factors; Treatment Failure	2011
Executive control in Parkinson's disease: effects of dopaminergic medication and deep brain stimulation on anti-cue keypress performance. Neuroscience letters, 2011, Aug-15, Volume: 500, Issue:2 Topics: Aged; Benserazide; Benzothiazoles; Carbidopa; Cues; Deep Brain Stimulation; Dopamine Agents; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Psychomotor Performance; Reaction Time; Subthalamic Nucleus	2011
Continuous buccolingual masticatory dyskinesia in Parkinson's disease. BMJ case reports, 2012, Sep-25, Volume: 2012 Topics: Aged; Antiparkinson Agents; Female; Humans; Levodopa; Male; Mastication; Movement Disorders; Parkinson Disease; Pergolide	2012
Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010. PloS one, 2014, Volume: 9, Issue:6 Topics: Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Drug Prescriptions; Ergolines; Female; Humans; Japan; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide	2014
The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets. European journal of pharmacology, 2015, Jan-15, Volume: 747 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Callithrix; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Female; Indoles; Levodopa; Male; Motor Activity; Pergolide; Purines; Receptor, Adenosine A2A	2015
The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets. European journal of pharmacology, 2015, Nov-05, Volume: 766 Topics: Adenosine A2 Receptor Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Callithrix; Dopamine Agonists; Drug Therapy, Combination; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Pergolide; Purines	2015